Kappa index for multiple sclerosis diagnosis: an accurate biomarker of intrathecal synthesis
- PMID: 39666131
- DOI: 10.1007/s00415-024-12826-y
Kappa index for multiple sclerosis diagnosis: an accurate biomarker of intrathecal synthesis
Abstract
Background: Cerebrospinal fluid (CSF) kappa-free light chains (KFLC) are becoming a diagnostic biomarker for multiple sclerosis (MS).
Objectives: We aimed to compare the diagnostic performance of intrathecal synthesis biomarkers to that of oligoclonal bands (OB) in diagnosing MS, radiological and clinical isolated syndromes (RIS-CIS) on a large cohort of patients collected over 10 years.
Methods: We collected 1124 patients (58% females) in 10 years who underwent CSF analysis for intrathecal synthesis in the diagnostic work-up, and they were classified according to their diagnosis as 417 MS, 287 with other neurological inflammatory disorders (including 76 RIS-CIS), and 420 non-inflammatory diseases (excluding lymphoproliferative and infective diagnosis).
Results: MS patients significantly differ from all other groups (including if considering the RIS-CIS cohort) for CSF KFLC, KFLC intrathecal fraction (IF), Kappa index, and OB. Evaluating the diagnostic performance, the Kappa index cut-off was 6.4 for diagnosing MS and 5.7 for predicting OB. A diagnostic algorithm could avoid IEF if the Kappa index is higher than 20.
Conclusions: The KFLC index confirmed its accuracy for MS diagnosis in this large Italian cohort, adding information also in the RIS-CIS population.
Keywords: Intrathecal synthesis; Kappa free light chains; Kappa index.
© 2024. Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Conflicts of interest: None for all authors for this work. Ethics approval: Local Ethical Committee approvals (Comitato Etico Interaziendale AOU “Maggiore della Carità” di Novara, ASL BI, ASL NO, ASL VCO): CE 060/2022 and 260/2022). Consent to participate/consent for publication: written consent obtained from all participants.
References
-
- Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162–173. https://doi.org/10.1016/S1474-4422(17)30470-2 - DOI - PubMed
-
- Freedman MS, Thompson EJ, Deisenhammer F et al (2005) Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 62(6):865–870. https://doi.org/10.1001/ARCHNEUR.62.6.865 - DOI - PubMed
-
- Christiansen M, Gjelstrup MC, Stilund M, Christensen T, Petersen T, Møller HJ (2019) Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis. Clin Chem Lab Med 57(2):210–220. https://doi.org/10.1515/CCLM-2018-0400/DOWNLOADASSET/SUPPL/CCLM-2018-040... - DOI
-
- Franciotta D, Lolli F (2007) Interlaboratory reproducibility of isoelectric focusing in oligoclonal band detection. Clin Chem 53(8):1557–1558. https://doi.org/10.1373/CLINCHEM.2007.089052 - DOI - PubMed
-
- Tibbling G, Link H, Öhman S (1977) Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Investig 37(5):385–390. https://doi.org/10.1080/00365517709091496 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous